tiprankstipranks
Trending News
More News >
AbCellera Biologics (ABCL)
NASDAQ:ABCL
US Market

AbCellera Biologics (ABCL) Income Statement

Compare
2,231 Followers

AbCellera Biologics Income Statement

Last quarter (Q3 2025), AbCellera Biologics's total revenue was $8.96M, an increase of 37.62% from the same quarter last year. In Q3, AbCellera Biologics's net income was $-57.12M. See AbCellera Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 28.83M$ 38.02M$ 485.42M$ 375.20M$ 233.16M
Gross Profit
$ 28.83M$ 38.02M$ 418.99M$ 329.69M$ 206.01M
Operating Expenses
$ 343.60M$ 275.23M$ 202.48M$ 125.27M$ 49.98M
Depreciation and Amortization
$ 97.00M$ 30.89M$ 33.10M$ 17.25M$ 5.27M
EBITDA
$ -204.15M$ -192.16M$ 260.17M$ 239.15M$ 169.62M
Operating Income
$ -314.77M$ -237.21M$ 216.51M$ 204.41M$ 156.03M
Other Income/Expenses
$ 114.37M$ 63.18M$ 22.59M$ 14.74M$ 1.80M
Pretax Income
$ -200.40M$ -174.03M$ 239.10M$ 219.15M$ 157.83M
Net Income
$ -162.86M$ -146.40M$ 158.52M$ 153.46M$ 118.92M
Per Share Metrics
Basic EPS
$ -0.55$ -0.51$ 0.56$ 0.56$ 0.32
Diluted EPS
$ -0.55$ -0.51$ 0.50$ 0.48$ 0.45
Weighted Average Shares Outstanding
294.33M 289.17M 285.06M 275.76M 267.82M
Weighted Average Shares Outstanding (Diluted)
294.33M 289.17M 314.83M 318.29M 263.13M
Currency in USD

AbCellera Biologics Earnings and Revenue History